Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Apyx Medical Corp

NASDAQ: APYX · Industrial Applications and Services · 2 alerts · CIK 719135

Share price
$2.65Close, Nov 16
Market cap
$112M
Shares outstanding
42.12MLatest SEC cover page
Sector
Industrial Applications and Services
Industry
Surgical & Medical Instruments & ApparatusSIC 3841

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Apyx Medical Corp filings on SEC EDGAR ↗

7:09 AM ET 8-K
Financial Results

Apyx Medical Financial Results

Apyx Medical reported Q3 2026 total revenue of $14.0 million, up 9% year-over-year, driven by 17% growth in its Surgical Aesthetics segment. The company narrowed its net loss to $1.8 million and achieved positive Adjusted EBITDA of $0.4 million while initiating the full commercial launch of its power liposuction handpiece for the AYON system.

Term
Q3 2026

“We are pleased to report 17% growth in our Surgical Aesthetics business for the quarter, reflecting continued adoption of AYON and the progress we are making in executing our commercial strategy. Over the past year, we have continued to demonstrate the value AYON offers by providing a full suite of complementary body contouring capabilities in one integrated platform. We are building on that foundation with the broader commercial launch of power liposuction, which has received very positive early feedback from surgeons since it received FDA clearance earlier this year. We estimate that approximately 70% of plastic surgeons use power liposuction, making this an important addition that broadens AYON’s appeal.”

Charlie Goodwin, President and Chief Executive Officer

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.